Greenfield Biologics Facility to produce blood plasma requires specialized wastewater pretreatment.

Baxter International constructed a $1.2 billion greenfield biologics facility in Covington, Georgia. This facility includes operations supporting plasma fractionation, purification, fill-finish and a testing lab. Complex facilities like these require specialized wastewater pretreatment. Since the construction Baxter has become Baxalta, Shire and now has been purchased by Takeda Pharmaceutical.

Experience matters with speed to market.

Haskell was selected by the Biologics Facility Contractor for the construction of the pre-treatment facility to treat wastewater flows generated by the operation of the plasma protein manufacturing. Haskell’s experienced construction team, combined with a trusted design partner, was able to complete the project and meet the aggressive schedule for the overall biologics facility.